Time to Update Lung-RADS v1.1? Incorporating evidence from recent observational studies.
Time to Update Lung-RADS v1.1? Incorporating evidence from recent observational studies.
复制标题
DOI：
10.1016/j.jacr.2022.06.010
复制
发表时间：
2023-09
影响因子：
4.5
通讯作者：
Wiener, Renda Soylemez
中科院分区：
文献类型：
--
作者：
Nunez, Eduardo R.;Gould, Michael K.;Wiener, Renda Soylemez
肺癌筛查（LCS）已被证明可使肺癌死亡率降低约20%。这种死亡率的降低取决于坚持适当的后续检测和每年重复筛查。ACR的肺CT筛查报告和数据系统（Lung- rads）的开发是为了标准化LCS结果的报告，根据癌症的可能性对结果进行分类，并包括后续测试的建议。本评论的目的是回顾支持更新当前Lung-RADS版本的证据，包括来自最近观察性研究的数据。最初版本的Lung-RADS v1。2014年发布的文献[2]提出了基于结节特征的LCS结果的不同分类[2]。如果未发现结节（Lung-RADS 1），建议每年进行一次筛查。对于有小结节的LCS检查（Lung-RADS 2-3），建议进行CT监测，监测间隔与检测给定大小的恶性结节生长的能力相对应。对于癌变可能性较高的较大结节（Lung-RADS 4），建议扩大到包括更强化的诊断检测（例如PET/CT或活检）。2019年，ACR发布了第二次更新，Lung-RADS v1。1由六项更新组成，旨在改善结节测量和减少非钙化结节的假阳性率[3]。2014年
Lung cancer screening (LCS) has been shown to reduce lung cancer mortality by approximately 20%[1]. This mortality reduction depends on adherence to appropriate follow-up testing and repeat annual screening. The ACR’s Lung CT Screening Reporting & Data System (Lung-RADS) was developed to standardize reporting of LCS results by categorizing findings according to probability of cancer and including a recommendation for follow-up testing. The objective of this commentary is to review evidence in support of updates to the current Lung-RADS version, including data from recent observational studies.The initial version of Lung-RADS v1. 0, released in 2014, proposed distinct categorization of LCS results based on nodule characteristics [2]. If no nodules are detected (Lung-RADS 1), annual screening is recommended. For LCS examinations with small nodules (Lung-RADS 2–3), CT surveillance is recommended, with the surveillance interval corresponding to the ability to detect growth of a malignant nodule of a given size. For larger nodules with a higher probability of cancer (Lung-RADS 4), recommendations expand to include more intensive diagnostic testing (eg, PET/CT or biopsy). In 2019, the ACR released a second update, Lung-RADS v1. 1 consisting of six updates with the intention of improving nodule measurements and reducing false-positive rates of noncalcified nodules [3]. Both the 2014
登录
查看更多内容
影响因子：
10.3
作者：
Aberle, Denise R.;Adams, Amanda M.;Pinsky, Paul F.
通讯作者：
Pinsky, Paul F.
影响因子：
9.6
作者：
Wiener, Renda Soylemez;Clark, Jack A.;Kathuria, Hasmeena
通讯作者：
Kathuria, Hasmeena
影响因子：
39.2
作者：
Henschke, Claudia I.;Yip, Rowena;Smith, James P.
通讯作者：
Smith, James P.
影响因子：
8.3
作者：
通讯作者：
--
影响因子：
8.3
作者：
Kim, Roger Y.;Rendle, Katharine A.;Vachani, Anil
通讯作者：
Vachani, Anil